Skip to main content

Prototype Prescribing Outlier Dashboard for Hebden Bridge Group Practice

At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing. These pilot results are provided for the interest of advanced users, although we don't know how relevant they are in practice. There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at [email protected]. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system, the count of all prescriptions within that chemical's BNF subparagraph, for prescriptions dispensed between June 2021 and December 2021. We then calculate the ratio of these counts along with the mean and standard deviation of those ratios across all Practices. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given Practice is from the population mean. We then rank your “z-scores” to find the top 10 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

For each outlier chemical, a kernel density estimation plot of all Practice's chemical:subparagraph ratios is provided, with this Practice's ratio overlaid in red.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not, to inform research on this topic. Our full analytical method code is openly available on GitHub here.

This is a new, experimental feature. We'd love to .

Prescribing where Hebden Bridge Group Practice is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Sulfur 2 Topical preparations for acne 163 0.01 0.00 0.00 26.37
Chlorhex hydrochloride 1 Preparations for minor cuts and abrasions 1 1.00 0.01 0.08 12.92
Levothyroxine sodium and liothyronine 33 Thyroid hormones 8,123 0.00 0.00 0.00 10.91
Magnesium carbonate 30 Antacids and simeticone 56 0.54 0.00 0.05 10.30
Other mouth wash, gargle and dentifrice preparations 10 Mouth-washes, gargles and dentifrices 35 0.29 0.00 0.03 8.86
Rifampicin combined preparations 1 Antituberculosis drugs 1 1.00 0.02 0.12 8.00
Wool alcohols 18 Emollients 468 0.04 0.00 0.01 4.63
Glimepiride 793 Sulfonylureas 1,324 0.60 0.07 0.13 3.96
Paraffin soft white 10 Emollients 468 0.02 0.00 0.01 3.89
Quinagolide hydrochloride 5 Bromocriptine and other dopaminergic drugs 8 0.62 0.04 0.16 3.76

Prescribing where Hebden Bridge Group Practice is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Gliclazide 524 Sulfonylureas 1,324 0.40 0.93 0.13 -3.95
Cabergoline 1 Bromocriptine and other dopaminergic drugs 8 0.12 0.86 0.27 -2.71
Chlorhexidine gluconate 25 Mouth-washes, gargles and dentifrices 35 0.71 0.97 0.11 -2.44
Rifampicin 0 Antituberculosis drugs 1 0.00 0.74 0.40 -1.88
    Loperamide hydrochloride 299 Antimotility drugs 305 0.98 1.00 0.01 -1.63
    Prucalopride 1 Other drugs used in constipation 5 0.20 0.71 0.32 -1.57
    Levothyroxine sodium 8,075 Thyroid hormones 8,123 0.99 1.00 0.00 -1.50
    Glucose blood testing reagents 694 Diabetic diagnostic and monitoring agents 775 0.90 0.94 0.03 -1.38
    Atenolol 438 Beta-adrenoceptor blocking drugs 7,414 0.06 0.13 0.05 -1.36
    Sodium cromoglicate 65 Other anti-inflammatory preparations 168 0.39 0.64 0.19 -1.35